Details of the Drug Formulations

General Information of Drug (ID: DMLVSYX)

• Drug Name: Remimazolam Drug Info
• Synonyms: CNS-7054; CNS-7056; CNS-7056B; CNS-7056X; GW-351564X; GW-418259X; GW-457837A; GW-502056X; ONO-2745; Short-acting sedatives, Therasci; GABA A agonist (anesthesia, sedation) CeNeS/Ono; Sedatives (short acting), CeNeS/Ono; Sedatives (short acting), PAION/Ono; Sedatives (short-acting), TheraSci; Short-acting sedatives, Therasci/GSK; Sedatives (short-acting), TheraSci/GSK

Indication

Disease Entry	ICD 11	Status	REF
Procedural sedation	JB0C.3	Approved	[1]
Anaesthesia	9A78.6	Phase 3	[2]

• Cross-matching ID:
  PubChem CID: 9867812
  CAS Number: 308242-62-8
  TTD ID: D0L5KU
  ACDINA ID: D01382

Full List of Drug Formulations Containing This Drug

Remimazolam 20 mg For Injection

Company	Formulation ID	FDA Description
Acacia Pharma	F23268	Dextran 40; Lactose Monohydrate; Hydrochloric Acid; Sodium Hydroxide

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8442).